Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Evaluation of Focused Ultrasound Ablation and Focused Ultrasound Ablation Plus PD-1 Antibody Blockade in Advanced Solid Tumors

NCT04116320 is registered in ClinicalTrials.gov with Craig L Slingluff, Jr as lead sponsor.

NCT NCT04116320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04116320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Evaluation of Focused Ultrasound Ablation and Focused Ultrasound Ablation Plus PD-1 Antibody Blockade in Advanced Solid Tumors
Lead sponsor
Craig L Slingluff, Jr
Phase
Phase 1
Overall status
Terminated
Start date
November 21, 2019
Completion date
August 15, 2023
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cervical cancer, esophageal cancer, gastric cancer, hepatocellular carcinoma, melanoma, merkel cell carcinoma, microsatellite instability high, non small cell lung cancer, ovarian cancer, small-cell lung cancer, squamous cell cancer, urothelial carcinoma